CHICAGO: The American Dental Association and a coalition of leading public health, medical, civil rights and community organizations are pushing back against a proposed U.S. Food and Drug Administration policy that critics say could make it easier for flavored vaping products to enter the U.S. market — potentially reigniting America’s youth nicotine addiction crisis.
In formal comments submitted to the FDA regarding the agency’s draft guidance on “Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications – Considerations Related to Youth Risk,” the coalition warned that the proposed framework risks weakening safeguards designed to protect teenagers and young adults from flavored nicotine products.
The organizations said they support the FDA’s long-standing scientific position that flavored e-cigarettes pose a “substantial risk to youth” and therefore should face strict scientific scrutiny before receiving marketing authorization.
At the heart of the debate is a question that has divided regulators, scientists, tobacco control advocates and the vaping industry for years: Do flavored e-cigarettes genuinely help adult smokers quit traditional cigarettes, or do they primarily create a new generation addicted to nicotine?
The FDA says its decisions are guided by a broader “public health standard” under the Family Smoking Prevention and Tobacco Control Act. Under this framework, the agency evaluates whether authorizing a vaping product would benefit overall public health by considering both the potential gains for adult smokers and the risks to youth populations.
Federal regulators argue that while vaping products are not safe, some e-cigarettes may expose adult smokers to fewer toxic chemicals than combustible cigarettes if users completely switch from smoking to vaping.
That harm-reduction argument has increasingly shaped FDA decisions in recent years.
Related story: ALERT! What every smoker, vaper must know before their next puff
In June 2024, the FDA authorized four menthol-flavored vaping products manufactured by NJOY after reviewing scientific data suggesting that some adult smokers were more likely to transition away from combustible cigarettes using menthol-flavored products than tobacco-flavored alternatives alone. The FDA said the authorization was based on evidence indicating a potential public health benefit for adult smokers, while also imposing marketing restrictions intended to reduce youth exposure.
At the same time, the FDA has rejected millions of applications for fruit-, candy- and dessert-flavored vaping products after concluding that manufacturers failed to prove the products offered enough smoking cessation benefits to outweigh the well-documented risks of youth nicotine addiction.
Public health groups, however, argue that the FDA’s latest proposal risks creating a dangerous regulatory loophole by treating some non-tobacco flavors — particularly menthol and mint — as lower-risk products requiring less evidence to gain authorization.
The coalition called that approach “fundamentally flawed,” warning that youth flavor preferences evolve rapidly and often shift in response to government restrictions themselves.
Health experts pointed to previous surges in youth use of mint- and menthol-flavored vaping products after restrictions were placed on sweeter cartridge-based flavors. According to the organizations, authorizing products viewed as “lower risk” today could simply redirect adolescent demand toward those products tomorrow.
Related story: Vape Tongue: Top dentist warns of disturbing new condition caused by vaping
The groups also challenged the FDA’s treatment of menthol as a comparatively safer flavor category.
Citing the FDA’s own prior scientific findings, the coalition noted that menthol products have long been associated with increased tobacco initiation among adolescents, stronger nicotine dependence, greater product appeal and reduced smoking cessation success rates.
“Given FDA’s conclusions that menthol increases initiation of tobacco products, leads to more regular use of tobacco products, makes it harder to stop using such products, makes these products more appealing to youth, and leads to greater youth usage, it is difficult to understand FDA’s classification of menthol ENDS products as ‘lower risk,’” the organizations wrote in their comments.
Related story: Vapes laced with nitazenes raise alarm over deadly health risks
The coalition further warned that the FDA’s current approach may underestimate the growing popularity of synthetic cooling agents and “ice”-style vaping products, which can create intense cooling sensations that mask nicotine harshness and potentially make vaping more attractive to younger or first-time users.
Experts urged regulators to evaluate not only flavor names but also the chemical composition of vaping liquids when assessing public health risks.
The organizations also agreed with the FDA that advertising restrictions and sales limitations alone are insufficient to prevent youth access to flavored products. However, they expressed skepticism over whether Device Access Restriction (DAR) technologies would meaningfully stop underage use without stronger independent scientific evidence.
The broader controversy reflects growing global alarm over rising adolescent vaping rates and mounting evidence linking flavored nicotine products to long-term addiction risks.
Medical and dental experts have repeatedly warned that nicotine exposure during adolescence can interfere with brain development, concentration, learning, mood regulation and impulse control. Dental professionals have also raised concerns about vaping-related oral health problems, including gum inflammation, enamel erosion, dry mouth, oral bacteria imbalance and increased risk of periodontal disease.
Critics of flavored vape authorizations say the FDA is attempting to balance two competing public health realities: helping long-term adult smokers move away from combustible cigarettes while simultaneously preventing a new generation from becoming addicted to nicotine.
Public health advocates argue that current scientific evidence still does not conclusively prove flavored vaping products outperform tobacco-flavored products in helping smokers permanently quit cigarettes.
The coalition concluded that lowering the scientific threshold for certain flavors could ultimately open “the regulatory door” to broader flavored vape availability across the U.S. market without sufficient evidence that the benefits to adults outweigh the risks to youth.
As the FDA faces mounting pressure from both anti-tobacco advocates and the vaping industry, the debate over flavored e-cigarettes is rapidly becoming one of the most consequential public health battles in America — with implications for parents, schools, healthcare systems, addiction specialists and millions of young consumers worldwide.
Stay informed, stay alert
CLICK HERE TO JOIN Medical News Pakistan on WhatsApp for real-time health alerts, expert insights, and breakthrough medical discoveries.
